CLYM
Price
$12.29
Change
+$0.11 (+0.90%)
Updated
Jun 23, 04:59 PM (EDT)
Capitalization
703.19M
56 days until earnings call
Intraday BUY SELL Signals
ZNTL
Price
$3.68
Change
+$0.01 (+0.27%)
Updated
Jun 23, 04:59 PM (EDT)
Capitalization
261.61M
50 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CLYM vs ZNTL

CLYM vs ZNTL Comparison Chart in %
View a ticker or compare two or three
VS
CLYM vs. ZNTL commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLYM is a Buy and ZNTL is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 24, 2026
Stock price -- (CLYM: $12.28 vs. ZNTL: $3.67)
Brand notoriety: CLYM and ZNTL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLYM: 110% vs. ZNTL: 68%
Market capitalization -- CLYM: $703.19M vs. ZNTL: $261.61M
CLYM [@Biotechnology] is valued at $703.19M. ZNTL’s [@Biotechnology] market capitalization is $261.61M. The market cap for tickers in the [@Biotechnology] industry ranges from $118.89B to $0. The average market capitalization across the [@Biotechnology] industry is $2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLYM’s FA Score shows that 0 FA rating(s) are green whileZNTL’s FA Score has 1 green FA rating(s).

  • CLYM’s FA Score: 0 green, 5 red.
  • ZNTL’s FA Score: 1 green, 4 red.
According to our system of comparison, both CLYM and ZNTL are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLYM’s TA Score shows that 3 TA indicator(s) are bullish while ZNTL’s TA Score has 4 bullish TA indicator(s).

  • CLYM’s TA Score: 3 bullish, 3 bearish.
  • ZNTL’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both CLYM and ZNTL are a good buy in the short-term.

Price Growth

CLYM (@Biotechnology) experienced а +14.66% price change this week, while ZNTL (@Biotechnology) price change was +4.40% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.83%. For the same industry, the average monthly price growth was +1.96%, and the average quarterly price growth was +1945.11%.

Reported Earning Dates

CLYM is expected to report earnings on Aug 18, 2026.

ZNTL is expected to report earnings on Aug 12, 2026.

Industries' Descriptions

@Biotechnology (+5.83% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CLYM($703M) has a higher market cap than ZNTL($262M). CLYM YTD gains are higher at: 204.000 vs. ZNTL (172.593). CLYM has higher annual earnings (EBITDA): -59.94M vs. ZNTL (-144.41M). ZNTL has more cash in the bank: 212M vs. CLYM (110M). CLYM has less debt than ZNTL: CLYM (479K) vs ZNTL (34.6M). CLYM (0) and ZNTL (0) have equivalent revenues.
CLYMZNTLCLYM / ZNTL
Capitalization703M262M268%
EBITDA-59.94M-144.41M42%
Gain YTD204.000172.593118%
P/E RatioN/AN/A-
Revenue00-
Total Cash110M212M52%
Total Debt479K34.6M1%
FUNDAMENTALS RATINGS
ZNTL: Fundamental Ratings
ZNTL
OUTLOOK RATING
1..100
8
VALUATION
overvalued / fair valued / undervalued
1..100
18
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CLYMZNTL
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
85%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 6 days ago
84%
Declines
ODDS (%)
Bearish Trend 21 days ago
88%
Bearish Trend 16 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 6 days ago
90%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
CLYM
Daily Signal:
Gain/Loss:
ZNTL
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MASKX32.470.27
+0.84%
iShares Russell 2000 Small-Cap Idx Instl
VWINX25.84N/A
N/A
Vanguard Wellesley® Income Inv
DSFRX40.69N/A
N/A
Domini Impact Equity Y
JFCAX34.57N/A
N/A
JHancock Fundamental All Cap Core A
LBWIX23.33N/A
N/A
BrandywineGLOBAL Div US Large Value I

CLYM and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLYM has been loosely correlated with KYTX. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if CLYM jumps, then KYTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLYM
1D Price
Change %
CLYM100%
+6.20%
KYTX - CLYM
40%
Loosely correlated
+2.91%
IMVT - CLYM
37%
Loosely correlated
+7.81%
ALGS - CLYM
34%
Loosely correlated
+7.39%
IMNM - CLYM
34%
Loosely correlated
+2.35%
ZNTL - CLYM
33%
Poorly correlated
-0.54%
More

ZNTL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZNTL has been loosely correlated with VCYT. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if ZNTL jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZNTL
1D Price
Change %
ZNTL100%
-0.54%
VCYT - ZNTL
39%
Loosely correlated
-0.82%
MLTX - ZNTL
38%
Loosely correlated
+15.33%
LPCN - ZNTL
38%
Loosely correlated
-1.72%
TIL - ZNTL
35%
Loosely correlated
+0.53%
EDIT - ZNTL
34%
Loosely correlated
+3.53%
More